✦ LIBER ✦

Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3

✍ Scribed by Alessandra Mangia; Franco Bandiera; Giuseppe Montalto; Leonardo Mottola; Valeria Piazzolla; Nicola Minerva; Adriano Pellicelli; Giovanni L. Ricci; Marina Cela; Vito Carretta; Gaetano Scotto; Donato Bacca; Brigida Annicchiarico; Mario Romano; Maurizio Russello; Giorgio Barbarini; Ernesto Agostinacchio; Angelo Andriulli

Book ID: 116652196
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 687 KB
Volume: 53
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2010.04.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDEN

630 RIBAVIRIN (RBV) DOSAGE AS INDEPENDENT PREDICTOR OF RVR IN HCV GENOTYPE 2 (HCV-2) AND 3 (HCV-3) PATIENTS UNDERGOING COMBINED TREATMENT WITH PEG INTERFERON (PEG-IFN) ALPHA-2B

✍ A. Mangia; O. Dalgard; N. Minerva; H. Verbaan; G. Scotto; D. Bacca; E. Agostinac 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Ribavirin dosage in patients with HCV ge

Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon α-2b and ribavirin

✍ A. MANGIA; O. DALGARD; N. MINERVA; H. VERBAAN; D. BACCA; H. RING-LARSEN; M. COPE 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Pegylated interferon-alpha 2b–ribavirin

Pegylated interferon-alpha 2b–ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis

✍ M. Derbala; A. Amer; A. Bener; A. C. Lopez; M. Omar; M. El Ghannam 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

Optimizing PEG-interferon and ribavirin

Optimizing PEG-interferon and ribavirin combination therapy for patients infected with HCV-2 or HCV-3: is the puzzle completed?

✍ Alfredo Alberti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB

Early discontinuation of ribavirin in HC

Early discontinuation of ribavirin in HCV genotype 2 and 3 patients undergoing short-treatment duration with Peg-interferon alfa 2a and ribavirin

✍ A. Andriulli; P. Andreone; C. Cursaro; R. Cozzolongo; N. Minerva; A. Iacobellis; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Treatment of chronic hepatitis C in HIV

Treatment of chronic hepatitis C in HIV infected patients (PTS) with pegylated interferon alpha 2B (PEG-IFN) plus ribavirin (RBV) versus pegylated interferon alpha 2B

✍ A. Cargnel; E. Angeli; A. Mainini; A. Casella; G. Gubertini; R. Giorgi; G. Orlan 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 156 KB